---
title: "Lionco released its first-quarter performance, with a net loss attributable to the parent company of 18.62 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237555707.md"
description: "According to the Zhitong Finance APP, Lionco disclosed its first-quarter report for 2025, showing that the company achieved revenue of 50.12 million yuan, a year-on-year decrease of 34.79%; the net profit attributable to the parent company was a loss of 18.62 million yuan; the net profit excluding non-recurring gains and losses was a loss of 17.91 million yuan. The basic earnings per share were -0.03 yuan"
datetime: "2025-04-25T10:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237555707.md)
  - [en](https://longbridge.com/en/news/237555707.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237555707.md)
---

# Lionco released its first-quarter performance, with a net loss attributable to the parent company of 18.62 million yuan

According to the Zhitong Finance APP, Lionco (603669.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 50.12 million yuan during the reporting period, a year-on-year decrease of 34.79%; the net profit attributable to shareholders was a loss of 18.62 million yuan; the net profit excluding non-recurring gains and losses was a loss of 17.91 million yuan. The basic earnings per share were -0.03 yuan

### Related Stocks

- [603669.CN](https://longbridge.com/en/quote/603669.CN.md)

## Related News & Research

- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)